In The Know-June 2026

June 2026
Pdf Summary
This monthly “Ed’s List” highlights notable gynecologic oncology literature published online or in print, spanning ovarian, cervical, endometrial, and rare gynecologic cancers, plus related surgical and public health studies.

Key themes include:
- <strong>Ovarian cancer biology and treatment:</strong> Studies describe circulating tumor cell phenotyping/genotyping in HGSOC, a detachment-responsive Rho GTPase (**RHOV**) essential for peritoneal metastasis, <strong>TPPP3</strong>-linked cisplatin resistance via microtubule rewiring, and <strong>GREM1/FGFR1</strong>-activated myofibroblasts that drive immunosuppression and metastasis. Real-world Japanese data map distinct clinicogenomic patterns across ovarian cancer histologies, while constitutional <strong>BRCA1 promoter methylation</strong> emerges as a potential risk biomarker.
- <strong>Therapy outcomes:</strong> An international cohort of patients with exceptional long-term response to <strong>PARP inhibitors</strong> showed durable progression-free survival, low late MDS/AML risk, and possible functional cure. For advanced ovarian cancer, outcomes after <strong>neoadjuvant chemotherapy vs primary surgery</strong> were similar after adjustment.
- <strong>Rare tumors:</strong> Integrated sequencing of <strong>endometrial stromal sarcoma</strong> identified grade-specific drivers, including <strong>RAD54B amplification</strong>, hypermutated subsets, and a promising NRAS-mutant xenograft response to MEK/FAK inhibition. An international study of <strong>adult ovarian germ cell tumors</strong> defined adverse prognostic factors such as stage III/IV, age ≥35, and nondysgerminoma histology.
- <strong>Cervical cancer and prevention:</strong> Inadvertent simple hysterectomy in low-risk early cervical cancer was associated with worse survival, and salvage chemoradiotherapy did not erase this disadvantage. Another study found <strong>CKC</strong> outperformed <strong>LEEP</strong> for long-term recurrence prevention and HPV clearance. Public trust in health institutions was linked to awareness that <strong>HPV causes cervical cancer</strong>.
- <strong>Surgery and prognosis:</strong> Robotic hysterectomy in endometrial cancer had lower conversion, readmission, and mortality than conventional laparoscopy. Surgeon <strong>social jet lag</strong> was associated with more postoperative adverse events. For locally advanced cervical cancer, para-aortic lymph node immune remodeling improved recurrence prediction.
- <strong>Risk/environment:</strong> Air pollution showed modest, geography-specific associations with ovarian and endometrial cancer risk. Sarcopenia and pretreatment muscle loss predicted poorer outcomes in endometrial cancer patients receiving immunotherapy.

Overall, the list emphasizes molecularly informed treatment, prognostic refinement, surgical quality, and prevention/public health.
Keywords
gynecologic oncology
ovarian cancer
cervical cancer
endometrial cancer
PARP inhibitors
BRCA1 promoter methylation
endometrial stromal sarcoma
HPV prevention
robotic hysterectomy
air pollution risk